Guoxu Fang
- Oncology top 5%
- Cancer-related Molecular Pathways 2
- Cancer Immunotherapy and Biomarkers 2
- Molecular Biology top 10%
-
- Cancer, Hypoxia, and Metabolism 2
- Cancer, Lipids, and Metabolism 2
- Physiology top 10%
- Surgery top 10%
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
-
- Radiomics and Machine Learning in Medical Imaging 5
-
- Ferroptosis and cancer prognosis 3
- Co-authors
- Jaana KorhonenMartin L. BreitmanTuija MustonenKari AlitaloArja KaipainenV W van HinsberghDaniel DumontJingfeng Liu
- Partner nations
- ChinaFinlandUnited States
In The Last Decade
Guoxu Fang
14 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Oncology 904
- Molecular Biology 835
- Cancer Research 123
- Physiology 191
- Surgery 285
Countries citing papers authored by Guoxu Fang
This map shows the geographic impact of Guoxu Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoxu Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoxu Fang more than expected).
Fields of papers citing papers by Guoxu Fang
This network shows the impact of papers produced by Guoxu Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoxu Fang. The network helps show where Guoxu Fang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guoxu Fang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 10 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 19 | |
| 13 | 2021 | 16 | |
| 14 | 2021 | 10 | |
| 15 | 2019 | 72 | |
| 16 | Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.breakdown → | 1995 | 1115 |
About Guoxu Fang
Guoxu Fang is a scholar working on Hepatology, Cancer Research and Oncology, having authored 16 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Radiomics and Machine Learning in Medical Imaging (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Ferroptosis and cancer prognosis (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer-related Molecular Pathways (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Oncology (904 citations), Molecular Biology (835 citations) and Cancer Research (123 citations). Guoxu Fang has collaborated with scholars based in China, Finland and United States. Frequent co-authors include Jaana Korhonen, Martin L. Breitman, Tuija Mustonen, Kari Alitalo, Arja Kaipainen, V W van Hinsbergh, Daniel Dumont, Jingfeng Liu, Rong Li and Peilin Zhang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.